Prudential Financial’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-23,831
Closed -$3.71M – 2306
2024
Q3
$3.71M Sell
23,831
-268
-1% -$43.3K 0.01% 1130
2024
Q2
$3.76M Buy
24,099
+5,314
+28% +$800K 0.01% 1050
2024
Q1
$2.55M Sell
18,785
-71
-0.4% -$9.4K ﹤0.01% 1298
2023
Q4
$2.54M Buy
18,856
+3,247
+21% +$422K ﹤0.01% 1289
2023
Q3
$2.11M Buy
15,609
+589
+4% +$80.4K ﹤0.01% 1334
2023
Q2
$2.15M Sell
15,020
-83
-0.5% -$12.2K ﹤0.01% 1362
2023
Q1
$1.99M Buy
15,103
+7,170
+90% +$965K ﹤0.01% 1350
2022
Q4
$1.08M Sell
7,933
-1,619
-17% -$203K ﹤0.01% 1669
2022
Q3
$1.05M Buy
9,552
+2,777
+41% +$352K ﹤0.01% 1730
2022
Q2
$908K Sell
6,775
-1,385
-17% -$182K ﹤0.01% 1840
2022
Q1
$1.08M Buy
8,160
+310
+4% +$37.2K ﹤0.01% 1836
2021
Q4
$1M Sell
7,850
-150
-2% -$17.6K ﹤0.01% 1879
2021
Q3
$889K Buy
8,000
+2,922
+58% +$340K ﹤0.01% 1871
2021
Q2
$608K Buy
5,078
+485
+11% +$53.2K ﹤0.01% 2064
2021
Q1
$457K Buy
4,593
+1,543
+51% +$155K ﹤0.01% 2159
2020
Q4
$305K Sell
3,050
-874
-22% -$92.6K ﹤0.01% 2240
2020
Q3
$430K Buy
3,924
+1,442
+58% +$160K ﹤0.01% 2010
2020
Q2
$262K Buy
+2,482
New +$256K ﹤0.01% 2156
2020
Q1
– Sell
-2,468
Closed -$246K – 2355
2019
Q4
$246K Buy
+2,468
New +$232K ﹤0.01% 2270

Other funds holding AZN

Prudential Financial's AZN Position: Q4 2024 in Review

Prudential Financial sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 23,831 shares — an estimated $3.71M sold.

Prudential Financial first reported a position in AZN in Q4 2019 and held it in 19 quarters. The position peaked at $3.76M in Q2 2024. 1,220 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • Prudential Financial reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 23,831 AstraZeneca shares in Q4 2024, an estimated $3.71M.
  • Prudential Financial first reported a position in AstraZeneca in Q4 2019 and held it in 19 quarters.
  • Prudential Financial's AstraZeneca position peaked at $3.76M in Q2 2024.
  • 1,220 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.